Description

Furo[2,3-B]Pyridine-5-Carboxamide, 2-[[[3-[(4-Amino-2-Pyrimidinyl)Thio]-2-Hydroxypropyl]Methylamino]Methyl]-n-[(4-Chlorophenyl)Methyl]-4,7-Dihydro-7- is a sophisticated heterocyclic organic compound of significant interest in advanced pharmaceutical research and development. This molecule serves as a critical pharmacological building block and key intermediate for the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting specific biological pathways.
• Kinase Inhibitor Research: Used in the development of potential kinase inhibitors for oncology and inflammatory disease applications.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization.
• Biochemical Research: Employed as a tool compound in biochemical assays to study enzyme function and cellular signaling.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for cutting-edge research in organic synthesis and drug discovery.

Basic Information

Item	Detail
Product Name	Furo[2,3-B]Pyridine-5-Carboxamide, 2-[[[3-[(4-Amino-2-Pyrimidinyl)Thio]-2-Hydroxypropyl]Methylamino]Methyl]-n-[(4-Chlorophenyl)Methyl]-4,7-Dihydro-7-
CAS No.	562101-73-9
Molecular Formula	C22H25ClN6O2S
Molecular Weight	472.99 g/mol
Synonyms	2-[[[3-[(4-Amino-2-pyrimidinyl)thio]-2-hydroxypropyl]methylamino]methyl]-N-[(4-chlorophenyl)methyl]-4,7-dihydro-7-oxofuro[2,3-b]pyridine-5-carboxamide; 7-Oxofuro[2,3-b]pyridine-5-carboxamide derivative; Furopyridinecarboxamide derivative; (4-Chlorobenzyl)-N-({2-[(3-{[(4-aminopyrimidin-2-yl)sulfanyl]-2-hydroxypropyl}methylamino)methyl]-4,7-dihydro-7-oxofuro[2,3-b]pyridin-5-yl})carboxamide; Research Compound 562101-73-9; Potential Kinase Inhibitor Intermediate.
EINECS	Contact for details

Quality Control

Our high-value pharmaceutical intermediates are produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting critical quality attributes. We support compliance with ICH guidelines for stability and impurity profiling.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is easily oxidized and should be handled under an inert atmosphere such as nitrogen or argon for long-term storage. Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.